<DOC>
	<DOC>NCT02981121</DOC>
	<brief_summary>The investigators will study prevention effect of Life style modification on diabetes mellitus comparing with conventional management and Metformin administration.</brief_summary>
	<brief_title>Hospital-based Diabetes Prevention Study in Korea</brief_title>
	<detailed_description />
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1. 31≤Age&lt;65 2. BMI≥23 kg/m2 3. 75g Oral glucose tolerance 2 hours after the test Blood glucose ≥ 200 mg / dL ' or 'Fasting Blood Sugar 100~125 mg/dL' or 'HbA1c 5.7%~6.4%' 1. Who diagnosed with Diabetes Mellitus or Who having Drugs for Diabetes Mellitus. 2. Type 2 Diabetes Mellitus Who diagnosed with Diabetes Mellitus except for maternity period. Who have had drugs for Diabetes Mellitus(hypoglycemic agent or insulin) except for maternity period. Fasting Glucose≥ 126 mg/dL 75g Oral glucose tolerance 2 hours after the Blood glucose ≥ 200 mg/dL HbA1c ≥ 6.5% 3. Who life expectancy is short. Cardiac history History of severe cardiovascular disease within the last 6 months (cerebral hemorrhage, stroke, myocardial infarction, angina pectoris, heart failure, etc.) Systolic blood pressure &gt;180 mmHg or Diastolic blood pressure &gt;105 mmHg aortic stenosis Left bundle branch block or Third degree AV block Who had been diagnosed and treated for malignant tumors including leukemia and lymphoma within the last 5 years Abnormal renal function (Creatinine ≥ 1.4 mg/dL (male) or ≥ 1.3 mg/dL (female) or Urine Protein ≥ 2 +) Anemia(Hematocrit &lt;36%((male) or&gt;&lt;33%(female)) ⑤ Cirrhosis or chronic active hepatitis (AST/ALT&gt;３UNL) Acute gastrointestinal disease (pancreatitis, infectious intestinal disease) Who is scheduled major surgery within the last 3 to 6 months or just after the surgery. Chronic infection (HIV, active tuberculosis, etc.) Pulmonary patients who rely on oxygen or daily bronchodilators 4. Who is judged to be able to influence the clinical trial by investigator. Who can not communicate Those with psychiatric or cognitive impairment that may affect the compliance of the clinical trial Those who do not agree to the treatment group allocation by random assignment Those who participate in other studies that may interfere with the clinical trial Those who lost weight by more than 10% during the past 6 months, excluding weight loss after giving birth Those who can not have normal walking or exercise Women who are pregnant Those who are currently pregnant or who are within the last 3 months after giving birth Those planning pregnancy during the clinical trial period Those who have a history of drug and alcohol abuse (acute, chronic) within the last 2 years Those who are not appropriate or unreliable for clinical trials at the discretion of the tester 5. Who taking medication or medical condition that may affect the diagnosis of diabetes Thiazide diuretics Systemic beta blockers Taking Niacin for the treatment of neutropenic depression Possibility of taking or injecting a systemic steroid preparation Taking a serotonin reuptake inhibitor (SSRI) for weight loss purpose. Taking medicine for weight loss Hormone status is not appropriate during thyroid hormone replacement therapy (TSH abnormal range) (If thyroid hormone therapy is stable for more than 3 months and TSH is normal, the patient can participate in) Others with other endocrine diseases (eg Cushing's syndrome, acromegaly) During treatment, fasting plasma triglyceride&gt; 600 mg / dL</criteria>
	<gender>All</gender>
	<minimum_age>31 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Diabetes Prevention</keyword>
</DOC>